Yield10 Bioscience Inc. [NASDAQ: YTEN] jumped around 5.96 points on Friday, while shares priced at $13.71 at the close of the session, up 76.90%. The company report on December 2, 2020 that Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 4th CRISPR AgBio Congress 2020 Virtual Event.
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced that Meghna Malik, Ph.D., Senior Director, will present at the 4th CRISPR AgBio Congress which is being held December 1-3, 2020 as a virtual event.
Dr. Malik’s presentation is titled “Yield10 trait development: Using CRISPR to increase seed yield and oil content in Camelina.” The presentation will be part of the “Expanding the CRISPR scope to more challenging agricultural crops” session which is scheduled at 6:00 pm EST on Dec. 2. Dr. Malik will also participate in a Virtual Roundtable titled “Analyzing the next generation of promising target traits: Revolutionizing the future of agriculture,” which is scheduled at 3:00 pm EST on Dec. 3.
Yield10 Bioscience Inc. stock is now 137.20% up from its year-to-date (YTD) trading value. YTEN Stock saw the intraday high of $14.4197 and lowest of $7.70 per share. The company’s 52-week high price is 14.69, which means current price is +143.95% above from all time high which was touched on 01/15/21.
Compared to the average trading volume of 71.95K shares, YTEN reached a trading volume of 3389877 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Yield10 Bioscience Inc. [YTEN]?
H.C. Wainwright have made an estimate for Yield10 Bioscience Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 10, 2020. The new note on the price target was released on August 27, 2020, representing the official price target for Yield10 Bioscience Inc. stock.
The Average True Range (ATR) for Yield10 Bioscience Inc. is set at 0.97, with the Price to Sales ratio for YTEN stock in the period of the last 12 months amounting to 63.46. The Price to Book ratio for the last quarter was 2.88, with the Price to Cash per share for the same quarter was set at 3.64.
How has YTEN stock performed recently?
Yield10 Bioscience Inc. [YTEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 93.10. With this latest performance, YTEN shares gained by 123.29% in over the last four-week period, additionally plugging by 117.62% over the last 6 months – not to mention a rise of 119.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for YTEN stock in for the last two-week period is set at 91.70, with the RSI for the last a single of trading hit 94.91, and the three-weeks RSI is set at 87.94 for Yield10 Bioscience Inc. [YTEN]. The present Moving Average for the last 50 days of trading for this stock 6.51, while it was recorded at 8.73 for the last single week of trading, and 6.14 for the last 200 days.
Yield10 Bioscience Inc. [YTEN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Yield10 Bioscience Inc. [YTEN] shares currently have an operating margin of -1066.50. Yield10 Bioscience Inc.’s Net Margin is presently recorded at -1607.44.
Return on Total Capital for YTEN is now -293.93, given the latest momentum, and Return on Invested Capital for the company is -493.84. Return on Equity for this stock declined to -1,591.65, with Return on Assets sitting at -104.01. Additionally, YTEN Total Debt to Total Capital is recorded at 3,103.68, with Total Debt to Total Assets ending up at 25.25.
Reflecting on the efficiency of the workforce at the company, Yield10 Bioscience Inc. [YTEN] managed to generate an average of -$518,240 per employee. Receivables Turnover for the company is 6.40 with a Total Asset Turnover recorded at a value of 0.06.Yield10 Bioscience Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.40 and a Current Ratio set at 8.40.
Earnings analysis for Yield10 Bioscience Inc. [YTEN]
With the latest financial reports released by the company, Yield10 Bioscience Inc. posted -12.02/share EPS, while the average EPS was predicted by analysts to be reported at -4/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -200.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for YTEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Yield10 Bioscience Inc. go to 0.00%.
Insider trade positions for Yield10 Bioscience Inc. [YTEN]
There are presently around $3 million, or 8.40% of YTEN stock, in the hands of institutional investors. The top three institutional holders of YTEN stocks are: CANNELL PETER B & CO INC with ownership of 93,125, which is approximately 75.294% of the company’s market cap and around 0.50% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 55,939 shares of the stock with an approximate value of $0.77 million in YTEN stocks shares; and WORTH VENTURE PARTNERS, LLC, currently with $0.54 million in YTEN stock with ownership of nearly New of the company’s market capitalization.
Positions in Yield10 Bioscience Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 9 institutional holders increased their position in Yield10 Bioscience Inc. [NASDAQ:YTEN] by around 136,882 shares. Additionally, 1 investors decreased positions by around 10,246 shares, while 5 investors held positions by with 99,796 shares. The mentioned changes placed institutional holdings at 246,924 shares, according to the latest SEC report filing. YTEN stock had 5 new institutional investments in for a total of 96,548 shares, while 1 institutional investors sold positions of 10,246 shares during the same period.